Ignite Creation Date:
2025-12-24 @ 9:24 PM
Ignite Modification Date:
2025-12-28 @ 6:42 AM
Study NCT ID:
NCT02122432
Status:
COMPLETED
Last Update Posted:
2015-06-22
First Post:
2014-04-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Teledermatology Versus Usual Care on Delay Before Diagnosis and Treatment of Dermatologic Conditions
Sponsor:
University Paris 7 - Denis Diderot
Organization:
Study Overview
Official Title:
Impact of Teledermatology Versus Usual Care on Delay Before Diagnosis and/or Treatment of Dermatologic Conditions in General Practice
Status:
COMPLETED
Status Verified Date:
2015-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TELEDERMATO
Brief Summary:
In France, there is usually a long delay (approximately 6 weeks) before a general practitioner can obtain a specialized advice by dermatologists for diagnosis of "unusual" dermatologic conditions of their patients.
Previous studies have shown that teledermatology is a reliable way for diagnosis in dermatology.
We hypothesize that a teledermatology advice could reduce delay before diagnosis and therefore treatment for patients.
Previous studies have shown that teledermatology is a reliable way for diagnosis in dermatology.
We hypothesize that a teledermatology advice could reduce delay before diagnosis and therefore treatment for patients.
Detailed Description:
In France, there is usually a long delay (approximately 6 weeks) before a general practitioner can obtain a specialized advice by dermatologists for diagnosis of "unusual" dermatologic conditions of their patients.
Previous studies have shown that teledermatology is a reliable way for diagnosis in dermatology.
We hypothesize that a teledermatology advice could reduce delay before diagnosis and therefore treatment for patients.
Previous studies have shown that teledermatology is a reliable way for diagnosis in dermatology.
We hypothesize that a teledermatology advice could reduce delay before diagnosis and therefore treatment for patients.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: